Fast Track designation is designed to expedite clinical development and regulatory review timelines Enrolling patients in the GLEAM trial for SC291 in B-cell mediated autoimmune diseases, including ...

Lupus Therapeutics introduces the IDEAL Initiative to fund clinical studies exploring the impact of diet and the microbiome ...

Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance (LRA), today announced a pioneering funding ...

A 42-year-old Black woman with no significant past medical history presents with blue-gray macules on her neck and upper chest that gradually developed over the past year.

Studies investigating what is damaging the kidney in lupus nephritis point to tubulointerstitial inflammation.

We investigate how candidate pathogenic bacteria in gut communities affect the immune system and potentially affect autoimmune disease activity.

Dapirolizumab pegol was better than a placebo at controlling disease activity in systemic lupus erythematosus patients in a Phase 3 trial.

Artificial intelligence is making impressive strides in its ability to read medical images. In a recent test in Britain's ...

Systemic lupus erythematosus is a potentially fatal autoimmune disease that is characterized by wide-spread inflammation and tissue damage that can affect any part of the body. Commonly affected ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window WASHINGTON -- Individuals with systemic lupus erythematosus (SLE) and multiple sclerosis (MS) had fewer herpes zoster ...

There are several lupus treatment options. However, there is no “best" treatment for lupus because each person living with the condition will have their own needs and goals for managing it. Lupus ...

Correspondence to Dr Maximilian F Konig, Division of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA; konig{at}jhmi.edu; Dr Philip C Robinson, The University of ...